Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antifungal Drugs Market

Antifungal Drugs Market Share

Report ID: GMI8582
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Antifungal Drugs Market Share

The antifungal drugs industry is characterized by intense competition among key players striving to gain a significant market share. Major pharmaceutical companies and generic drug manufacturers are actively involved in research, development, and commercialization of antifungal medications. Strategic collaborations, partnerships, mergers, and acquisitions are common strategies employed by key players to strengthen their market position and capitalize on emerging opportunities in the global market.

Antifungal Drugs Market Companies

Prominent players operating in the antifungal drugs industry include:

Abbott Laboratories
Astellas Pharma, Inc.
Bayer AG
Enzon Pharmaceuticals, Inc.
GlaxoSmithKline plc
Glenmark
Merck & Co., Inc.
Novartis AG
Pfizer, Inc.
Sanofi

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for antifungal drugs was valued at USD 15.5 billion in 2023 and is anticipated to reach USD 21.2 billion by 2032, backed by the increasing prevalence of fungal infections due to a growing geriatric population, and a higher number of immunocompromised patients.

The azoles segment accounted for a 48.2% market share in 2023 and will continue to be prominent through 2032, as they exhibit a broad spectrum of activity against a wide range of fungal pathogens, including Candida species, Aspergillus species, and dermatophytes.

North America market accounted for a revenue of USD 6.4 billion in 2023 and is anticipated to record a CAGR of 3.3% through 2032, attributed to the presence of advanced healthcare infrastructure and sophisticated medical facilities, which facilitate early diagnosis, treatment, and management of fungal infections.

Abbott Laboratories, Astellas Pharma, Inc., Bayer AG, Enzon Pharmaceuticals, Inc., GlaxoSmithKline plc, Glenmark, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi among others.